Literature DB >> 16991011

[Rheumatoid arthritis and cardiovascular complications].

W Seidel1, M Hecker, U Wagner, H Häntzschel.   

Abstract

Rheumatoid arthritis is associated with increased morbidity and mortality due to cardiovascular events. Elevated concentrations of acute-phase proteins and cytokines and endothelial dysfunction, demonstrated also by lack of traditional risk factors, play an important role in these complications. Antirheumatic drug treatment can modify the frequency and severity of cardiovascular events.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16991011     DOI： 10.1007/s00393-006-0103-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  38 in total

1.  Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction.

Authors:  Lorenz M Fischer; Raymond G Schlienger; Christian M Matter; Hershel Jick; Christoph R Meier
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

2.  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Authors:  Lennart T H Jacobsson; Carl Turesson; Anders Gülfe; Meliha C Kapetanovic; Ingemar F Petersson; Tore Saxne; Pierre Geborek
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

Review 3.  Coronary artery disease and rheumatoid arthritis.

Authors:  Nicola Goodson
Journal:  Curr Opin Rheumatol       Date:  2002-03       Impact factor: 5.006

4.  Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis.

Authors:  Inmaculada del Rincón; Gregory L Freeman; Roy W Haas; Daniel H O'Leary; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2005-11

5.  Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.

Authors:  T Pincus; L F Callahan
Journal:  J Rheumatol       Date:  1986-10       Impact factor: 4.666

Review 6.  [Cardiovascular manifestations in rheumatoid arthritis].

Authors:  F Moritz; U Wagner; O Distler; W Seidel; S Gay; H Häntzschel
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

Review 7.  Flow-mediated dilatation.

Authors:  O T Raitakari; D S Celermajer
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

8.  Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.

Authors:  Paulo J Nicola; Cynthia S Crowson; Hilal Maradit-Kremers; Karla V Ballman; Véronique L Roger; Steven J Jacobsen; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2006-01

9.  Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.

Authors:  S Wållberg-Jonsson; H Johansson; M L Ohman; S Rantapää-Dahlqvist
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

10.  The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

Authors:  Paulo J Nicola; Hilal Maradit-Kremers; Véronique L Roger; Steven J Jacobsen; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02
View more
  1 in total

Review 1.  [A gene defect in the promoter of the endothelial NO synthase as a risk factor for rheumatoid arthritis].

Authors:  I Melchers; M Cattaruzza
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.